# Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis

> **NCT05796401** · PHASE3 · RECRUITING · sponsor: **Centre Hospitalier St Anne** · enrollment: 500 (estimated)

## Conditions studied

- Psychosis

## Interventions

- **BEHAVIORAL:** Cognitive training
- **DRUG:** Personalized neuroprotective strategies : Vitamin B12, folinic acid, Omega 3, NAC
- **OTHER:** Treatment as usual (TAU)

## Key facts

- **NCT ID:** NCT05796401
- **Lead sponsor:** Centre Hospitalier St Anne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-15
- **Primary completion:** 2026-12-15
- **Final completion:** 2029-02-15
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05796401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05796401, "Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05796401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*